Navigation Links
Journal ONCOLOGY and CancerNetwork Now Bringing Readers Select ACR Appropriateness Criteria
Date:8/29/2013

NORWALK, Conn., Aug. 29, 2013 /PRNewswire/ -- UBM Medica US announces that starting with its August issue, the journal ONCOLOGY will offer its readers, once every quarter, the valuable resource of the American College of Radiology (ACR) Appropriateness Criteria. The Criteria will both appear in the print journal and be available on the CancerNetwork, the online home of the journal ONCOLOGY.

The ACR Appropriateness Criteria in ONCOLOGY's August issue focus on the management of localized nodal indolent lymphoma. The Criteria are presented in a unique and convenient format, utilizing five case examples (called "variants") of indolent lymphoma, with levels of appropriateness for specific treatment recommendations for each variant.

Known for its practical and authoritative review articles, ONCOLOGY has played an important role in the ongoing education of countless practicing oncologists/hematologists. The quarterly publication of ACR Appropriateness Criteria being inaugurated in the current issue will serve to further enhance the journal's ability to meet the needs of its readership.

About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit www.UBMMedicaUS.com.

About UBM plc
UBM plc is a global events-led marketing services and communications company.  We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content.  Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.

For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.

Media contact:
Jason J. Golden
Content Marketing Manager
203-523-7040
jason.golden@ubm.com


'/>"/>
SOURCE UBM Medica US
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
2. Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
3. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
4. 1st Case Report of Using Single-Site Cannulation ECMO to Treat SynCardia Total Artificial Heart Patient Published in Journal of Cardiothoracic Surgery
5. Philadelphia Business Journal has named Hope Paige Medical ID one of its Best Places to Work in Philadelphia
6. Leadership Through Research Collaboration Is Reflected In Articles Published In Alzheimers Association Journal
7. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
8. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
9. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiënten voor 44% minder bloedstroominfecties zorgt
10. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
11. Journal of Managed Care Pharmacy recognizes Prime Therapeutics with two 2012 JMCP Award for Excellence Honorable Mentions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... AMSTERDAM , December 8, 2016 Information ... TM metrics in Scopus , the world,s largest ... free access to comprehensive metrics for journals from over 5,000 publishers. ... publish, which journals to subscribe to and when to adjust a ... , , ...
(Date:12/8/2016)... 2016 According to the research report, ... is expected to be worth US$9.7 bn by the ... Between the forecast years of 2016 and 2024, the global ... The leading players operating in the global diabetes injection pens ... plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports ...
(Date:12/8/2016)... 2016 According to a new market research report ... Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, Patch), ... global market, in terms of value, is projected to reach 12.14 Billion ... 18.0% during the forecast period. Continue Reading ... ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 2016 , ... David J. Dykeman , Ginger Pigott , and ... speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. ... firm’s global Life Sciences & Medical Technology Group have been featured speakers at every ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are encouraged to ... mind, SIGVARIS has created a new line of anti-embolism stockings to help prevent ... the benefits of graduated compression when transitioning from recovery to early rehabilitation. , ...
Breaking Medicine News(10 mins):